Trial · NCT00619229
Outcomes11
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 11 of 11
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Difference in Visual Acuity Between Measurements at 3 Months After Drug Intervention and Measurements at Baseline (Assessed Within Early Treatment Diabetic Retinopathy Study (ETDRS) Chart) | From baseline to 3 months | Full Analysis Set (FAS) | Lines read in ETDRS chart | MEAN |
| SECONDARY | The Difference in Visual Acuity Between Measurements Immediately After Intervention and Measurements at Baseline | From baseline to time immediately after intervention | Full Analysis Set (FAS) | Lines read in ETDRS chart | MEAN |
| SECONDARY | The Difference in Visual Acuity Between Measurements at 6 Months After Intervention and Measurements at Baseline | From baseline to 6 months | Full Analysis Set (FAS) | Lines read in ETDRS chart | MEAN |
| SECONDARY | Progression of the Dry Age-related Macular Degeneration | From baseline to 6 months | Full Analysis Set (FAS) | Participants | NUMBER |
| SECONDARY | Development of a Wet Age-related Macular Degeneration | From baseline to 6 months | Full Analysis Set (FAS) | Participants | NUMBER |
| SECONDARY | The Difference in Contrast Sensitivity Between Measurements Immediately After Intervention and Measurements at Baseline | From baseline to time immediately after intervention | Full Analysis Set (FAS) | Unit on a scale | MEAN |
| SECONDARY | The Difference in Contrast Sensitivity Between Measurements at 3 Months After Intervention and Measurements at Baseline | From baseline to 3 months | Full Analysis Set (FAS) | Unit on a scale | MEAN |
| SECONDARY | The Difference in Contrast Sensitivity Between Measurements at 6 Months After Intervention and Measurements at Baseline | From baseline to 6 months | Full Analysis Set (FAS) | Unit on a scale | MEAN |
| SECONDARY | The Difference in Color Vision Between Measurements Immediately After Intervention and Measurements at Baseline | From baseline to time immediately after intervention | Full Analysis Set (FAS) | Participants | NUMBER |
| SECONDARY | The Difference in Color Vision Between Measurements at 3 Months After Intervention and Measurements at Baseline | From baseline to 3 months | Full Analysis Set (FAS) | Participants | NUMBER |
| SECONDARY | The Difference in Color Vision Between Measurements at 6 Months After Intervention and Measurements at Baseline | From baseline to 6 months | Full Analysis Set (FAS) | Participants | NUMBER |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00619229/outcomes